singlet oxygen has been researched along with Cancer of Prostate in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Akkaya, EU; Li, J; Liu, Y; Liu, Z; Pan, Y; Tang, L; Wang, L; Wu, H | 1 |
Kirakci, K; Koncošová, M; Lang, K; Mikyšková, R; Reiniš, M; Ruml, T; Rumlová, M; Zelenka, J | 1 |
Fedoruk-Wyszomirska, A; Gdaniec, M; Goslinski, T; Kaczmarek, M; Kucinska, M; Mielcarek, J; Murias, M; Sciepura, M; Skupin-Mrugalska, P; Sobotta, L; Szczolko, W; Teubert, A; Tykarska, E; Wierzchowski, M; Wyszko, E | 1 |
Bui, B; Chen, W; Liu, L | 1 |
Baratti, MO; da Silva, AR; Inada, NM; Jorge, RA; Rettori, D; Vercesi, AE | 1 |
Dysart, JS; Patterson, MS | 1 |
Chiu , SM; Oleinick, NL; Xue , LY | 1 |
7 other study(ies) available for singlet oxygen and Cancer of Prostate
Article | Year |
---|---|
Prostate-specific membrane antigen (PSMA) targeted singlet oxygen delivery
Topics: Antigens, Surface; Cell Line, Tumor; Glutamate Carboxypeptidase II; Humans; Ligands; Male; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Singlet Oxygen | 2022 |
Avenue to X-ray-induced photodynamic therapy of prostatic carcinoma with octahedral molybdenum cluster nanoparticles.
Topics: Animals; Carcinoma; Humans; Male; Mice; Molybdenum; Nanoparticles; Photochemotherapy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Singlet Oxygen; X-Rays | 2022 |
Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Crystallography, X-Ray; Enzyme-Linked Immunosorbent Assay; Humans; Indoles; Isoindoles; Light; Male; Melanoma; Molecular Structure; Morpholines; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Singlet Oxygen; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |
Latex carrier for improving protoporphyrin IX for photodynamic therapy.
Topics: Cell Line, Tumor; Cell Survival; Drug Stability; Humans; Hydrogen Bonding; Latex; Male; Molecular Structure; Nanoparticles; Photochemotherapy; Prostatic Neoplasms; Protoporphyrins; Singlet Oxygen; Solubility | 2016 |
In vitro photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Carriers; Electron Spin Resonance Spectroscopy; Fluorescence; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Light; Male; Metalloporphyrins; Nanoparticles; Particle Size; Photobleaching; Photochemical Processes; Photochemotherapy; Photosensitizing Agents; Polyglactin 910; Prostatic Neoplasms; Singlet Oxygen; Surface Properties | 2009 |
Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Topics: Adenocarcinoma; Algorithms; Animals; Cell Line, Tumor; Cell Survival; Dihematoporphyrin Ether; Dose-Response Relationship, Radiation; Light; Male; Oxygen Consumption; Photobleaching; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Rats; Singlet Oxygen | 2005 |
Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.
Topics: Adenocarcinoma; Animals; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; CHO Cells; Cricetinae; Cricetulus; Female; Free Radical Scavengers; Histidine; Humans; Indoles; Intracellular Membranes; Laryngeal Neoplasms; Male; Membrane Proteins; Molecular Weight; Neoplasm Proteins; Oxidative Stress; Oxygen; Photochemistry; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Singlet Oxygen; Tumor Cells, Cultured | 2001 |